MIST icon

Milestone Pharmaceuticals
MIST

Overview Fund Activity

25 hedge funds and large institutions have $231M invested in Milestone Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
+2
Holders Change %
+8.7%
% of All Funds
0.49%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
4
Increased
8
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TCM
1
Tekla Capital Management
Massachusetts
$12M
2
RI
2
RTW Investments
New York
$63.4M
3
O
3
OrbiMed
New York
$5.83M
4
ACP
4
Acuta Capital Partners
California
$8.14M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$9.61M

Top Sellers

1
BBA
1
Baker Bros. Advisors
New York
$0
2
NHAS
2
Novo Holdings A/S
Denmark
$39M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$20.6M
4
OAM
4
Oxford Asset Management
United Kingdom
$316K
5
Invesco
5
Invesco
Georgia
$5.16M
Name Holding Trade Value Shares
Change 		Shares
Change %
BBA
26
Baker Bros. Advisors
New York
– -$4.97M -266,667 Closed
CCA
27
Catalyst Capital Advisors
New York
– -$9K -500 Closed
1
2